Full name
ETYKA OŚRODEK BADAŃ KLINICZNYCH TOMASZ PESTA SPÓŁKA KOMANDYTOWO-AKCYJNA
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
68.20.Z - Rental and operating of own or leased real estate
82.11.Z - Office administrative service activities
86.90.E - Other human health activities notelsewhere classified
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Assets | 0,3 | 0,8 | 188,7 |
Gross profit (loss) | 0 | 1,5 | 6410,1 |
EBITDA | 0 | 1,5 | 4188,3 |
Net profit (loss) | 0 | 1,3 | 6610,5 |
Cash | 0 | 0,5 | 1569,1 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | -61,7 |
Net income from sale | 0,7 | 2,7 | 316 |
Short time liabilities | 0,2 | 0,1 | -61,7 |
Working assets | 0,3 | 0,8 | 188,7 |
Equity capital | 0,1 | 0,7 | 968,5 |
Operating profit (EBIT) | 0 | 1,5 | 5395,2 |
Depreciation | 0 | 0 | -100 |
% | % | p.p. | |
Profitability of capital | 28,6 | 179,6 | 151 |
Equity capital to total assets | 24,3 | 90 | 65,7 |
Gross profit margin | 3,5 | 54,4 | 50,9 |
EBITDA Margin | 5,4 | 56 | 50,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 122 | 11 | -111 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane